| 1FBZ: Structure-Based Design Of A Novel, Osteoclast-Selective, Non Src Sh2 Inhibitor With In Vivo Anti-Resorptive Activity reference: Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity., Shakespeare W, Yang M, Bohacek R, Cerasoli F, Stebbins K, Sundaramoorthi R, Azimioara M, Vu C, Pradeepan S, Metcalf C 3rd, Haraldson C, Merry T, Dalgarno D, Narula S, Hatada M, Lu X, van Schravendijk MR, Adams S, Violette S, Smith J, Guan W, Bartlett C, Herson J, Iuliucci J, Weigele M, Sawyer T, Proc Natl Acad Sci U S A 2000 Aug 15;97(17):9373-8. PMID: 10944210 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).